课题基金 / 基金详情

SALBUTAMOL SULFATE IN PATIENTS WITH REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE

SALBUTAMOL SULFATE IN PATIENTS WITH REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE
硫酸沙丁胺醇治疗可逆性阻塞性气道疾病患者
批准号:
2480023
负责人:
金额:
$2.31万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective of this study is to compare the long-term safety of a hydrofluroalbane propellent (non-ozone depleting) with that of the standard chloroflurocarbon based propellant used in metered-dose inhalers. The secondary objective of this study is to evaluate the safety and efficacy of salbutamol sulfate in those subjects who were randomized to receive Ventolin (trade name for salbutamol) in a previous study. This study has been completed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金